Latest Patent Grant Is Driving VYNE Therapeutics Stock Higher Today
VYNE Therapeutics Inc. (NASDAQ: VYNE) is seeing a significant boost in the price of its stock today. As of the last check during current session, VYNE stock was up 11.11% to $2.50. A notable developments in VYNE’s portfolio of intellectual property is the driving force behind that surge. Announcement of Patent Grant VYNE Therapeutics unveiled […]
VYNE Therapeutics Inc. (VYNE) had a Bearish Spell, Here’s Why
VYNE Therapeutics Inc. (VYNE), a pharmaceutical company, has surged 7.7% in aftermarket trading session and consequently is trading at $0.74 at the time of the writing. On Monday, VYNE closed the day at $0.6871 after plummeting by 12.53% during regular trading hours. The massive slide was attributable to the divestment of topical minocycline assets. Why […]